Julie A Irving Selected Research

Carcinoma (Carcinomatosis)

1/2019	High-grade Endometrial Carcinomas: Morphologic and Immunohistochemical Features, Diagnostic Challenges and Recommendations.
11/2013	HNF-1β in ovarian carcinomas with serous and clear cell change.
11/2004	Molecular genetic alterations in endometrioid carcinomas of the ovary: similar frequency of beta-catenin abnormalities but lower rate of microsatellite instability and PTEN alterations than in uterine endometrioid carcinomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Julie A Irving Research Topics

Disease

9	Neoplasms (Cancer) 01/2023 - 11/2004
4	Endometrioid Carcinoma 01/2019 - 11/2004
3	Carcinoma (Carcinomatosis) 01/2019 - 11/2004
1	Endometrial Stromal Sarcoma 01/2023
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 01/2018
1	Leukemia 01/2017
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2017
1	Carcinogenesis 10/2015
1	Endometriosis 05/2014
1	Ovarian Neoplasms (Ovarian Cancer) 11/2013
1	Endometrial Hyperplasia 02/2013
1	Wilms Tumor (Wilm's Tumor) 07/2008
1	Endometrial Stromal Tumors 01/2006
1	Leiomyosarcoma 07/2005
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 07/2005
1	Microsatellite Instability 11/2004
1	Neutropenia 07/2003
1	Cytopenia 07/2003
1	Anemia 07/2003

Drug/Important Bio-Agent (IBA)

3	beta CateninIBA 01/2018 - 11/2004
3	Inhibins (Inhibin)IBA 10/2015 - 01/2006
3	Calbindin 2IBA 10/2015 - 01/2006
2	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2019
2	Mucin-1 (CA 15-3 Antigen)IBA 01/2019 - 03/2009
2	VimentinIBA 10/2015 - 03/2009
1	Hormones (Hormone)IBA 01/2019
1	Cadherins (E-Cadherin)IBA 01/2019
1	Dasatinib (BMS 354825)FDA Link 01/2017
1	tirbanibulinIBA 01/2017
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	Cyclin D1IBA 10/2015
1	CateninsIBA 10/2015
1	MucinsIBA 05/2014
1	Progestins (Progestagens)IBA 02/2013
1	Keratins (Keratin)IBA 03/2009
1	Estrogen ReceptorsIBA 07/2008
1	MART-1 AntigenIBA 01/2006
1	DesminIBA 07/2005
1	Matrix Metalloproteinase 7 (Matrilysin)IBA 11/2004
1	CopperIBA 07/2003
1	ZincIBA 07/2003
1	ElementsIBA 07/2003

Therapy/Procedure

2	Therapeutics 12/2008 - 07/2005
1	Drug Therapy (Chemotherapy) 11/2013